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Sir
Recently Lord and colleagues (1998) published a paper in this
journal in which they claimed that preconceptional paternal
irradiation (PPI) with 239Pu substantially affected development of
haemopoietic stem cells, produced cytogenetic aberrations, and
markedly altered and increased cancer induction following intra-
venous injection of male mice with 50 mg kg–1 methyl-nitroso-urea
(MNU). They speculated that the cancer effects and the cytogenetic
aberrations might result from the effects on haemopoietic stem
cells, which had to result from transmitted radiation-induced muta-
tions if PPI was the cause. I will provide some of the reasons why it
seems implausible that PPI was responsible for the claimed cancer
effects. Indeed, from the way in which the data were presented, it is
unclear whether PPI had any effect in the Lord et al study.
The paper presented no dosimetry to estimate the doses in mGy
of PPI that resulted from their injections of male mice with either
128 or 256 Bq g–1 of 239Pu-citrate. (These two dose groups will be
referred to as the 128-PPI and 256-PPI groups.) Comparisons with
extensive studies (NCRP 1981) of the mutational effects of
injections of 370 Bq g–1 of 239Pu-citrate at Oak Ridge National
Laboratory (ORNL) provide a means for estimating that, at most,
the doses in the 128-PPI and 256-PPI groups were 160 and
310 mGy, respectively. Knowledge of these doses is useful for
comparisons below.
The following three specific effects on MNU-induced cancer
induction were reported to result from PPI (and thus from
radiation-induced mutations): markedly reduced time until first
neoplasm, considerable shortening of the time required until 50%
of the mice developed malignancy, and a pronounced shift from
thymic lymphomas to leukaemias. Because of the manner of data
presentation, it takes some effort to ascertain the induced frequen-
cies of radiation-induced mutations required to yield the observed
effects. The observed mutation frequencies for each dose can be
derived by multiplying the percentage of mice developing cancer
by day 250 after MNU injection times the fraction of that group
said to have leukaemia. Accordingly, for the doses of 0, 160 and
310 mGy, the observed mutation frequencies are 26%, 60% and
53% respectively. Induced mutation frequencies, calculated by
subtracting control from experimental, are 34% and 27% in the
160 and 310 mGy groups respectively. It is emphasized that
these mutation frequencies are for a very specific type of domi-
nant mutation that causes mice to develop leukaemia (instead
of thymic lymphoma) within 250 days after treatment with
50 mg kg–1 MNU.
Such high induced mutation frequencies for such a narrowly-
defined type of mutation, based on samples of only 62 and 41
offspring respectively, seem extraordinarily improbable if one
considers results that have been found following injection of male
mice with 239Pu-citrate for induction of types of gene mutations
that have been considered useful for conventional hereditary risk
estimation (UNSCEAR, 1993). In 186 275 offspring of male mice
that received a mean dose of 1200 mGy of this type of PPI (with a
range of 250–2750 mGy), there were 37 specific-locus mutations
(NCRP, 1981). Correcting for the spontaneous mutation
frequency, this is an induced mutation frequency of about 0.015%
for recessive mutations at the combined total of seven genes
studied in that method. (On average, those genes are thought to be
much more mutable than most mammalian genes.) Because of
concern raised by the specific-locus results that some of the
induced mutations might have had adverse dominant effects on
viability, and because of results showing that similar Pu treatments
induce dominant lethal mutations (Lüning et al, 1976), I did a large
experiment to investigate the effects of PPI from 239Pu-citrate in
inducing dominant skeletal mutations. The mean dose to the
fathers was 580 mGy. The observed frequencies of newly-arising
presumed dominant skeletal mutations were six in 3353 offspring
in the experimental group and three in 1987 offspring in the
concurrent control (Selby, 1990). The point estimate of the
induced mutation frequency was 0.03% per gamete, which did not
approach statistical significance. This frequency relates to induc-
tion of dominant mutations at a presumably vast number of genes
capable of causing such skeletal malformations when they do
mutate (Selby, 1990).
ORNL specific-locus and heritable translocation results for
239Pu-citrate have another important bearing on speculation in the
Lord et al paper because they provide evidence that the
dose–response is linear over the long exposure times involved,
with no indication of a humped dose–response that might suggest
a higher response with lower doses (NCRP, 1981). While humped
dose–responses are well known for doses of radiation that cause
extensive spermatogonial killing, there is no basis for invoking
that phenomenon for doses as small as those in the Lord et al
study. Reports of radiation-induced genetic instability in somatic
cells and cells in culture sometimes indicate a much higher
response than can be attributed to DNA damage; however, extra-
polation of such findings in an attempt to explain the implausibly
high induced mutation frequencies in the present study would be
unreasonable because DNA changes that result in transmission to
offspring are (with rare exceptions not applicable here) only inher-
ited by one animal per mutation.
It seems clear from the above that the observed cancer differ-
ences have nothing to do with the injected plutonium-citrate
solutions. The true explanation may lie in a poorly defined under-
standing of the variation in the cancer response from replicate to
replicate when such small samples of mice are injected with MNU
(without any injection of Pu-citrate). Alternatively, some bias may
have inadvertently crept into the experiment. Surprisingly little
detail is provided for the cancer part of the study, for example,
regarding such things as the distributions of types and timings of
the malignancies among the different litters.
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The authors also claimed that PPI altered cell populations in the
haemopoietic system and induced cytogenetic damage; however,
the magnitudes of those effects were slight in comparison with the
extremely high induced mutation frequencies needed to explain
their cancer results, as discussed above. Regarding the haemopoi-
etic system, they concluded that PPI led to substantial alterations
in certain cell populations, as exemplified by large increases in
variability between animals but no changes in means. My main
concern with this part of their paper relates to the normalizing
procedure that was used to demonstrate increased variability in
experimental groups. Examination of the summary data in Table 2
of their paper shows a high degree of variability between laborato-
ries and strains. In view of the numerous significant differences, it
is puzzling that the justification given by the authors for applying
their normalizing procedure was ‘to compensate for minor varia-
tions resulting from assays at different times, different venues and
different mice’ (p. 304). If the normalizing procedure was unjusti-
fied, their claimed effect may be no more than an artifact that
tricked them into thinking that plutonium was inducing more vari-
ability. In view of the authors’ conclusion, it also seems curious
that the variances (as calculated from the summary data in their
Table 2) of the experimental groups are not larger than those of the
control groups, on average. It is interesting that ANOVA compar-
isons of individual dose groupings (with other variables held
constant) showed that dose was often a significant factor, but
responses were about as likely to go down, as up, with increasing
dose.
Regarding the authors’ conclusion that cytogenetic aberrations
(mostly chromatid-type) resulted from PPI, I expect that important
aberrations would show up in all cells containing chromosomes,
regardless of tissue. They did not. In addition, there was a signifi-
cant (P < 0.05) dose–response only in 2-day marrow. Because the
aberration data also showed considerable variability, their inter-
pretation regarding a possible effect of PPI demands considerable
caution. In the face of so much variability in the cytogenetic and
haemopoietic data, the authors simply provided too little informa-
tion for anyone to evaluate carefully whether their data support
their claims. That shortcoming becomes critical when one
considers the implausibility that such small doses of PPI would
influence numerous offspring in such a small study.
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Reasons it is doubtful that preconceptional paternal
irradiation with plutonium-239 had any effect on cancer
induction by methyl-nitroso-urea￿reply
Sir
Dr Selby doubts the concept or hypothesis that preconception
paternal irradiation (PPI) can have any influence on patterns of
malignancy in offspring of that irradiated father. He is not alone.
In particular he concludes that our ‘observed cancer differences
(Lord et al, 1998a) have nothing to do with the injected 
plutonium’. It appears that he does, at least, accept that there
were cancer differences. One should look first at what we did. We
injected male mice with 239Pu and waited 12 weeks, thus ensuring
continuous irradiation to, and throughout, an entire spermatogenic
cycle, before mating with normal females. Their offspring were
treated with methyl-nitroso-urea (MNU), which is known to
induce thymic lymphoma and myeloid leukaemia. We observed
acceleration and amplification of that process in the offspring of
those mice injected with 239Pu compared to controls injected only
with the carrier solution. Paternally injected plutonium was the
only difference between the groups. We naturally concluded that
239Pu was the obvious link to the enhanced malignancy rate. We
did not claim that it caused the malignancies. Indeed, we pointed
out that without the MNU induction, no malignancies resulted.
Neither, and most importantly, did we claim to understand the
mechanisms. We simply reported the observations and threw out a
few possible suggestions.
We would ask to take into account also a companion paper
(Lord et al, 1998b), which Dr Selby has either missed or ignored
and where we obtained similar results when using 3.3 Gy g-rays as
the secondary induction agent rather than MNU. In addition, we
may now add that g-ray PPI can be equally effective (KP Hoyes
and BI Lord, to be published). Cumulatively, these experiments
now represent groups approaching 200 mice in each arm of the
study though even at the original 50 per group, the incidence
statistics are more than favourable when compared with the size ofgroups accepted in epidemiological studies. Furthermore, varia-
tion from replicate to replicate did not appear to be a problem. Our
control groups matched exactly the cancer incidence reported 24
years earlier by Dexter et al (1974). We do not believe group size
was a contributory factor in these observations. The statistics were
analysed and the differences proved significant.
The main part of Dr Selby’s argument lies in the expected
potential mutation frequencies induced by 239Pu and whether these
match the guestimated frequencies he calculates from our observa-
tions. His estimates of radiation dose are probably reasonable. In
response to questions we estimated 65 and 130 mGy over 3
months (Lord et al, 1998b). We assume Dr Selby’s calculated
doses are over 3 months also; he does not say. However, we have
tended to play its significance down since it means so little. It is an
average dose and takes no account of the inhomogeniety of dose
distribution from an incorporated a-emitter and a single a-particle
hit has been estimated to deliver about 0.5 Gy to, for example,
stem cells in haemopoietic tissue (Lorimore et al, 1993). For
equivalence in fertility effects we found it appropriate to deliver
3 Gy to the fathers in our new acute g-irradiation studies. Dr Selby,
therefore, is probably underestimating the radiation-induced muta-
tion frequencies. He emphasizes that they must be of a specific
type that causes leukaemia to develop. This is not the case. MNU
causes the leukaemia to develop, probably in all the mice if
thymomas did not develop first. PPI is only required to accelerate
the development of leukaemia when triggered by MNU.
All Dr Selby’s analysis is based on classical point mutation
genetics. It is now clear that the phenomenon of genomic insta-
bility is a potential outcome of radiation exposure (see Mothersill,
1998); latent damage, which can be exposed after considerable
delays and after completion of multiple cycles of apparently
normal division with no mutations. It is not, therefore, necessarily
detected by the classical methods. Much emphasis is now placed
on potential ‘bystander’ effects (see Mothersill, 1998), which can
amplify the frequency of these unstable mutations by virtue of
unexpected interactions between irradiated and non-irradiated
cells. This, in itself, would lead to different aberration rates in
different tissues – a point highlighted by Dr Selby. There is
evidence of epigenetic inheritance of defects in the germline and
Cox (1992) described a number of ways in which genes may
‘break the rules’, concluding that ‘It is now clear that non-
Mendelian (epigenetic) processes operating during gamete forma-
tion can influence tumour susceptibility in man’.
Unlike in a court of law, where the recent case trying the
validity of the PPI hypothesis was lost on ‘the balance of probabil-
ities’, a scientific observation cannot be dismissed simply because
it ‘seems extraordinarily improbable’. A lack of understanding of
the mechanisms does not, of itself, invalidate an observation.
BI Lord
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